Patent · US Active

Method of preparing recombinant adeno-associated virus and recombinant baculovirus

US11180736B2 · kind B2 · utility

0Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 29, 2018
Grant dateNov 23, 2021
Priority date
Expiry dateJan 9, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/22
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A method for producing a recombinant adeno-associated virus (rAAV) and a recombinant baculovirus virus, the method including: (1) infecting an insect host packaging cell line with a corresponding recombinant baculovirus integrated with an rAAV genome ITR-GOI (gene of interest flanked by AAV inverted terminal repeats) and an AAV Cap gene or AAV Rep gene; (2) culturing the host packaging cell line infected with the recombinant baculovirus, so as to produce the recombinant adeno-associated virus; and (3) separating and purifying the recombinant adeno-associated virus obtained in (2).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.